If young child exposed, consider neglect or intentional harm
Child protection services notification per local protocol
Thorough social history and home environment assessment
Background
Epidemiology
Prevalence and trends
Peak US emergency department visits from synthetic cathinones 2010 to 2012
AAPCC data: >22,000 calls related to bath salts in 2012
Decline after DEA emergency scheduling of MDPV, mephedrone, methylone in 2011
Ongoing emergence of novel synthetic cathinones
Alpha-PVP (flakka) major epidemic 2014 to 2015 particularly in Florida
Novel agents continuously synthesised to evade scheduling
Demographics
Young adults 18 to 35 predominantly
Male predominance
Geographic clustering around areas of high drug availability
Mortality and morbidity
Death uncommon with early recognition and aggressive management
Mortality from hyperthermia, rhabdomyolysis-induced renal failure, cardiac arrest, or restraint-related asphyxia
Psychiatric morbidity: psychosis may persist days to weeks after last use
Pathophysiology
Mechanism of action
Monoamine reuptake inhibition and release
Blocks dopamine, norepinephrine, and serotonin transporters
Net effect: massive increase in synaptic monoamine levels
Potency comparison
MDPV has 10-fold greater potency than cocaine at dopamine transporter
Mephedrone acts similarly to MDMA with prominent serotonergic effects
Methylone more balanced dopamine and serotonin effects
Sympathomimetic toxidrome mechanism
Excess catecholamines cause hypertension, tachycardia, and hyperthermia
Peripheral vasoconstriction from alpha-adrenergic activation
Coronary vasospasm from direct vascular effects
Downstream complications
Hyperthermia pathway
Agitation and muscle hyperactivity generate heat
Impaired heat dissipation from vasoconstriction and diaphoresis
Core temperature >42°C causes protein denaturation
Rhabdomyolysis cascade
Muscle breakdown releases myoglobin
Myoglobin precipitates in renal tubules causing AKI
CK elevation correlates with muscle injury severity
Cardiac injury mechanism
Catecholamine-mediated direct myocardial toxicity
Coronary vasospasm can cause STEMI with normal coronaries
Takotsubo cardiomyopathy from catecholamine surge
Therapeutic Considerations
Evidence basis for treatment
No randomised controlled trials for bath salts toxicity treatment
Benzodiazepines first-line based on class effect in sympathomimetic toxicity
Extrapolated from cocaine and amphetamine toxicity literature
Expert consensus and AHA 2025 guidelines endorse benzodiazepines
ASAM/AAAP 2024 guideline on stimulant use disorder
Supports dexmedetomidine for severe hyperadrenergic states
Supports alpha-2 agonists (clonidine) for mild to moderate cases
AHA 2023 focused update on cardiac arrest in toxicity
Emphasises benzodiazepines for stimulant-induced dysrhythmias
ECMO consideration for refractory cardiogenic shock
Pharmacological strategy principles
Treat the toxidrome, not the specific agent
Exact cathinone rarely identified acutely
Sympathomimetic toxidrome management applies regardless of agent
Avoid drugs that worsen QTc or lower seizure threshold
Phenothiazines, typical antipsychotics with caution
Phenytoin not useful for toxicologic seizures
Titrate to effect rather than fixed doses
Benzodiazepine doses may be 10 to 20 times standard for severe agitation
Intubation preferable to inadequate sedation
Long-term considerations
High addictive potential of synthetic cathinones
Psychotic symptoms may persist days to weeks after abstinence
Addiction medicine referral prior to discharge
Synthetic cathinones can unmask underlying psychiatric illness
Patient Discharge Instructions
copy discharge instructions
Bath salts toxicity discharge instructions
You were treated in the emergency department for toxicity from synthetic stimulants called bath salts
These drugs can cause severe side effects including agitation, high blood pressure, racing heart, high body temperature, muscle breakdown, and kidney damage
Your lab work and heart monitoring were checked before discharge
Activity and recovery instructions
Rest at home for the next 24 to 48 hours
Drink plenty of fluids to support your kidneys
Do not use bath salts or other synthetic stimulants
Do not drink alcohol for at least 72 hours
Avoid strenuous exercise until cleared by a doctor
Return to the emergency department immediately if you experience
New or returning confusion or agitation
Chest pain or irregular heartbeat
Dark brown or tea-coloured urine
Decreased urination despite drinking fluids
Fever above 38.5°C
Seizure
Thoughts of harming yourself or others
Muscle pain that is getting worse
Follow-up appointments
See your primary care provider within 3 to 5 days
Psychiatry follow-up if you experienced hallucinations or paranoia that has not fully resolved
Addiction medicine or substance use program referral is strongly recommended
Repeat blood tests for kidney function and CK in 3 to 5 days if instructed
Important safety information
Synthetic cathinones are highly addictive with unpredictable potency
These substances are often mislabelled and contaminated
Mixing with alcohol or other drugs significantly increases risk of death
Psychotic symptoms can persist for days to weeks after last use
Naloxone (Narcan) does not reverse bath salts toxicity
References
Guidelines and key sources
Primary guidelines
AHA 2025 Guidelines Part 10: Adult and Pediatric Special Circumstances of Resuscitation (Cao D et al, Circulation 2025)
Benzodiazepines endorsed as first-line for stimulant-induced cardiac and neurologic toxicity
AHA 2023 Focused Update on Management of Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning (Lavonas EJ et al, Circulation 2023)
ECMO consideration for refractory cardiogenic shock from stimulant toxicity
ASAM/AAAP Clinical Practice Guideline on Management of Stimulant Use Disorder (Journal of Addiction Medicine 2024)
Dexmedetomidine for severe hyperadrenergic states
Alpha-2 agonists for mild to moderate cases
Landmark studies and case series
Ross EA et al: Psychoactive Bath Salts Intoxication With MDPV (Am J Medicine 2012)
Clinical characterisation of MDPV toxidrome
Banks ML et al: Synthetic Cathinones (J Emergency Medicine 2014)
Pharmacology, clinical presentation, and treatment review
Imam SF et al: Bath Salts Intoxication Case Series (J Emergency Medicine 2013)
Clinical characteristics and ED management outcomes
Miotto K et al: Clinical and Pharmacological Aspects of Bath Salt Use (Drug Alcohol Dependence 2013)
Psychiatric sequelae and addiction potential
Pieprzyca E et al: Toxicological Analysis of Synthetic Cathinone Intoxications (J Analytical Toxicology 2022)
Laboratory detection methods and confirmatory testing
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.